Latent profiles of regulatory flexibility in alcohol use disorder: Associations with delay discounting and symptoms of depression, anxiety, and stress

• Published in: Alcohol, clinical & experimental research clinical & experimental research, 2024-01, Vol.48 (1), p.188-198
• Main Authors: Dwyer, Candice L., Craft, William H., Tomlinson, Devin C., Tegge, Allison N., Kim‐Spoon, Jungmeen, Bickel, Warren K.
• Format: Article
• Language: English
• Subjects: alcohol use disorder; delay discounting; emotion regulation; regulatory flexibility
• ISSN: 2993-7175; 2993-7175
• DOI: 10.1111/acer.15235

Background Regulatory flexibility (RF) involves three distinct components of self‐regulation: context sensitivity, repertoire, and feedback responsiveness. Subgroups based on differences in RF have been identified in a general sample and are differentially associated with symptoms of anxiety and depression. However, potential RF profiles have not been examined in individuals with substance use disorders. This study examined RF subtypes in individuals with alcohol use disorder (AUD) and their associations with psychosocial outcomes (i.e., depression, anxiety, and stress) and delay discounting (a core feature of addiction). Methods Individuals (n = 200) with an Alcohol Use Disorders Identification Test score of >16 (mean = 24.12 (±6.92)) were recruited from Amazon Mechanical Turk (mean = 37.26 years old (±11.41); 94 (47%) women). Participants completed the Context Sensitivity Index, the Flexible Regulation of Emotional Expression Scale, and the Coping Flexibility Scale to assess RF. Participants also completed an Adjusting Amount Delay Discounting Task and the Depression, Anxiety, and Stress Scale (DASS‐21). Latent profile analyses (LPA) were used to identify patterns in RF deficits. Kruskal–Wallis and Dunn's tests were performed to examine differences in discounting rates and symptoms of depression, anxiety, and stress across RF profiles. Results The LPA revealed a 2‐profile characterization, including (1) context sensitive regulators (CSR; n = 39) and (2) moderate flexibility regulators (MFR; n = 161). CSR demonstrated significantly lower symptoms of depression (p = 0.004), anxiety (p